DrugPatentWatch Database Preview
Profile for Peru Patent: 13112008
US Patent Family Members and Approved Drugs for Peru Patent: 13112008
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Mar 8, 2028 | Celgene | REVLIMID | lenalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |